Neuroprotective effects of Gymnema sylvestre on streptozotocin-induced diabetic neuropathy in rats

Experimental and Therapeutic Medicine

Volumn 9, Issue 5, 2015, Pages 1670-1678

  Fatani, Amal Jamil ^a   Al Rejaie, Salim Salih ^a   Abuohashish, Hatem Mustafa ^a,b   Al Assaf, Abdullah ^c   Parmar, Mihir Yogeshkumar ^a   Ola, Mohammad Shamsul ^d   Ahmed, Mohammed Mahboobuddin ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

^c College of Food and Agricultural Sciences   (Saudi Arabia)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Gymnema sylvestre; Hyperglycemic neuropathy; Inflammation; Oxidative stress

Indexed keywords

ALCOHOL; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GYMNEMA SYLVESTRE EXTRACT; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTOPEROXIDASE; MALONALDEHYDE; NERVE GROWTH FACTOR; NITRIC OXIDE; SOMATOMEDIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERALGESIA; INSULIN BLOOD LEVEL; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PAIN THRESHOLD; RAT; SCIATIC NERVE; STREPTOZOTOCIN-INDUCED DIABETIC NEUROPATHY; TAIL FLICK TEST; WESTERN BLOTTING;

EID: 84925061119     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2305     Document Type: Article

References (48)

1. Callaghan BC, Little AA, Feldman EL and Hughes RA: Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev 6: CD007543, 2012.
2. Galer BS, Gianas A and Jensen MP: Painful diabetic polyneuropathy: Epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 47: 123-128, 2000.
3. Cameron NE and Cotter MA: Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res Clin Pract 45: 137-146, 1999.
4. Stevens MJ, Obrosova I, Cao X, Van Huysen C and Greene DA: Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 49: 1006-1015, 2000.
5. Calcutt NA: Experimental models of painful diabetic neuropathy. J Neurol Sci 220: 137-139, 2004.
6. Sima AA, Zhang W, Xu G, et al: A comparison of diabetic polyneuropathy in type II diabetic BBZDR/Wor rats and in type I diabetic BB/Wor rats. Diabetologia 43: 786-793, 2000.
7. Edwards JL, Vincent AM, Cheng HT and Feldman EL: Diabetic neuropathy: Mechanisms to management. Pharmacol Ther 120: 1-34, 2008.
8. Ceriello A: Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes. Curr Opin Lipidol 17: 510-518, 2006.
9. Figueroa-Romero C, Sadidi M and Feldman EL: Mechanisms of disease: The oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord 9: 301-314, 2008.
10. Zherebitskaya E, Akude E, Smith DR and Fernyhough P: Development of selective axonopathy in adult sensory neurons isolated from diabetic rats: Role of glucose-induced oxidative stress. Diabetes 58: 1356-1364, 2009.
11. Cunha JM, Jolivalt CG, Ramos KM, Gregory JA, Calcutt NA and Mizisin AP: Elevated lipid peroxidation and DNA oxidation in nerve from diabetic rats: Effects of aldose reductase inhibition, insulin, and neurotrophic factors. Metabolism 57: 873-881, 2008.
12. Yeh GY, Eisenberg DM, Kaptchuk TJ and Phillips RS: Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 26: 1277-1294, 2003.
13. Kanetkar P, Singhal R and Kamat M: Gymnema sylvestre: A Memoir. J Clin Biochem Nutr 41: 77-81, 2007.
14. Daisy P, Eliza J and Mohamed Farook KA: A novel dihydroxy gymnemic triacetate isolated from Gymnema sylvestre possessing normoglycemic and hypolipidemic activity on STZ-induced diabetic rats. J Ethnopharmacol 126: 339-344, 2009.
15. Ramkumar KM, Ponmanickam P, Velayuthaprabhu S, Archunan G and Rajaguru P: Protective effect of Gymnema montanum against renal damage in experimental diabetic rats. Food Chem Toxicol 47: 2516-2521, 2009.
16. Grover JK, Yadav S and Vats V: Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol 81: 81-100, 2002.
17. Ye WC, Zhang QW, Liu X, Che CT and Zhao SX: Oleanane saponins from Gymnema sylvestre. Phytochemistry 53: 893-899, 2000.
18. Surveswaran S, Cai YZ, Xing J, Corke H and Sun M: Antioxidant properties and principal phenolic phytochemicals of Indian medicinal plants from Asclepiadoideae and Periplocoideae. Nat Prod Res 24: 206-221, 2010.
19. Al-Rejaie SS, Abuohashish HM, Ahmed MM, Aleisa AM and Alkhamees O: Possible biochemical effects following inhibition of ethanol-induced gastric mucosa damage by Gymnema sylvestre in male Wistar albino rats. Pharm Biol 50: 1542-1550, 2012.
20. Aleisa AM, Al-Rejaie SS, Abuohashish HM, Ola MS, Parmar MY and Ahmed MM: Pretreatment of Gymnema sylvestre revealed the protection against acetic acid-induced ulcerative colitis in rats. BMC Complement Altern Med 14: 49, 2014.
21. Sedlak J and Lindsay RH: Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 25: 192-205, 1968.
22. Kono Y: Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186: 189-195, 1978.
23. Aebi H: Catalase In: Methods in Enzymatic Analysis. Bergmeyer (ed.), New York, pp674-684, 1974.
24. Kamboj SS, Vasishta RK and Sandhir R: N-acetylcysteine inhibits hyperglycemia-induced oxidative stress and apoptosis markers in diabetic neuropathy. J Neurochem 112: 77-91, 2010.
25. AlSharari SD, Al-Rejaie SS, Abuohashish HM, Aleisa AM, Parmar MY and Ahmed MM: Ameliorative potential of morin in streptozotocin-induced neuropathic pain in rats. Trop J Pharm Res 13: 1429-1436, 2014.
26. El Shafey AAM, El-Ezabi MM, Seliem MME, Ouda HHM and Ibrahim DS: Effect of Gymnema sylvestre R. Br. leaves extract on certain physiological parameters of diabetic rats. Journal of King Saud University-Science 25: 135-141, 2013.
27. Verma N, Shakya VK and Saxena RC: Antidiabetic activity of glycoside isolated from Gymnema sylvestre in streptozotocin induced diabetic rats. Asian J Chem 20: 5033-5036, 2008.
28. Yoshioka S: Inhibitory effects of gymnemic acid and an extract from the leaves of Ziziphus jujuba on glucose absorption in the rat small intestine. J Yonago Med Assoc 37: 142-154, 1986.
29. Fushiki T, Kojima A, Imoto T, Inoue K and Sugimoto E: An extract of Gymnema sylvestre leaves and purified gymnemic acid inhibits glucose-stimulated gastric inhibitory peptide secretion in rats. J Nutr 122: 2367-2373, 1992.
30. Sahu NP, Mahato SB, Sarkar SK and Poddar G: Triterpenoid saponins from Gymnema sylvestre. Phytochemistry 41: 1181-1185, 1996.
31. Bolajoko EB, Mossanda KS, Adeniyi F, Akinosun O, Fasanmade A and Moropane M: Antioxidant and oxidative stress status in type 2 diabetes and diabetic foot ulcer. S Afr Med J 98: 614-617, 2008.
32. Julius U, Drel VR, Grässler J and Obrosova IG: Nitrosylated proteins in monocytes as a new marker of oxidative-nitrosative stress in diabetic subjects with macroangiopathy. Exp Clin Endocrinol Diabetes 117: 72-77, 2009.
33. Bonnefont-Rousselot D: Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care 5: 561-568, 2002.
34. Halliwell B: Drug antioxidant effects. A basis for drug selection? Drugs 42: 569-605, 1991.
35. Preuss HG, Jarrell ST, Scheckenbach R, Lieberman S and Anderson RA: Comparative effects of chromium, vanadium and Gymnema sylvestre on sugar-induced blood pressure elevations in SHR. J Am Coll Nutr 17: 116-123, 1998.
36. Kang MH, Lee MS, Choi MK, Min KS and Shibamoto T: Hypoglycemic activity of Gymnema sylvestre extracts on oxidative stress and antioxidant status in diabetic rats. J Agric Food Chem 60: 2517-2524, 2012.
37. Kumar V, Bhandari U, Tripathi CD and Khanna G: Evaluation of antiobesity and cardioprotective effect of Gymnema sylvestre extract in murine model. Indian J Pharmacol 44: 607-613, 2012.
38. Sharma K, Singh U, Vats S, Priyadarsini K, Bhatia A and Kamal R: Evaluation of evidenced-based radioprotective efficacy of Gymnema sylvestre leaves in mice brain. J Environ Pathol Toxicol Oncol 28: 311-323, 2009.
39. Rachh PR, Patel SR, Hirpara HV, et al: In vitro evaluation of antioxidant activity of Gymnema sylvestre R. BR. leaf extract. Rom J Biol 54: 141-148, 2009.
40. Brownlee M: The pathobiology of diabetic complications: A unifying mechanism. Diabetes 54: 1615-1625, 2005.
41. Navarro-González JF and Mora-Fernández C: The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 19: 433-442, 2008.
42. Li J, Wei GH, Huang H, Lan YP, Liu B, Liu H, Zhang W and Zuo YX: Nerve injury-related autoimmunity activation leads to chronic inflammation and chronic neuropathic pain. Anesthesiology 118: 416-429, 2013.
43. Djordjevic A, Bursac B, Velickovic N, Vasiljevic A and Matic G: The impact of different fructose loads on insulin sensitivity, inflammation, and PSA-NCAM-mediated plasticity in the hippocampus of fructose-fed male rats. Nutr Neurosci 18: 66-75, 2015.
44. Diwan PV, Margaret I and Ramakrishna S: Influence of Gymnema sylvestre on inflammation. Inflammopharmacology 3: 271-277, 1995.
45. Jitender KM, Manvi F, Alagawadi K and Noolvi M: Evaluation of anti-inflammatory activity of Gymnema sylvestre leaves extract in rats. IJGP 2: 114-115, 2008.
46. Yasukawa K, Okuda S and Nobushi Y: Inhibitory effects of Gymnema (Gymnema sylvestre) leaves on tumour promotion in two-stage mouse skin carcinogenesis. Evid Based Complement Alternat Med 2014: 328684, 2014.
47. Scarth JP: Modulation of the growth hormone-insulin-like growth factor (GH-IGF) axis by pharmaceutical, nutraceutical and environmental xenobiotics: An emerging role for xenobiotic-metabolizing enzymes and the transcription factors regulating their expression. A review. Xenobiotica 36: 119-218, 2006.
48. Freeman RS, Burch RL, Crowder RJ, Lomb DJ, Schoell MC, Straub JA and Xie L: NGF deprivation-induced gene expression: After ten years, where do we stand? Prog Brain Res 146: 111-126, 2004.